Loading chat...

NY S02722

Bill

Status

Engrossed

4/24/2017

Primary Sponsor

Jeffrey Klein

Click for details

Origin

Senate

2017-2018 General Assembly

AI Summary

  • Defines "controlled substance analogue" as a substance with chemical structure substantially similar to Schedule I or II controlled substances that produces similar or greater stimulant, depressant, or hallucinogenic effects on the central nervous system.

  • Establishes that controlled substance analogues are deemed equivalent to their parent controlled substances for all legal purposes under New York law.

  • Excludes from the definition: actual controlled substances, substances with FDA-approved new drug applications, and substances with valid FDA investigational use exemptions.

  • Modifies the definition of "knowingly" for analogue-related offenses to not require knowledge of chemical structure, only that the person knew or should have known of the substance's psychoactive effects or represented it as such.

  • Takes effect immediately upon passage.

Legislative Description

Provides that a controlled substance analogue shall be deemed to be the controlled substance to which it is substantially similar or mimics.

Last Action

COMMITTED TO RULES

6/20/2018

Committee Referrals

Rules6/20/2018
Health1/3/2018
Health4/24/2017
Health1/17/2017

Full Bill Text

No bill text available